Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease.

cardiovascular disease fibroblast activation protein fibrosis gallium-68 myocardial injury positron emission tomography

Journal

Frontiers in nuclear medicine (Lausanne, Switzerland)
ISSN: 2673-8880
Titre abrégé: Front Nucl Med
Pays: Switzerland
ID NLM: 9918470388806676

Informations de publication

Date de publication:
2023
Historique:
received: 18 05 2023
accepted: 29 06 2023
medline: 27 7 2023
pubmed: 27 7 2023
entrez: 2 10 2024
Statut: epublish

Résumé

Gallium-68 fibroblast activation protein inhibitor [(

Identifiants

DOI: 10.3389/fnume.2023.1224905 PMID: 39355018 PMC: PMC11440833
pubmed: 39355018
doi: 10.3389/fnume.2023.1224905
pmc: PMC11440833
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1224905

Informations de copyright

© 2023 Mpanya, Sathekge, Klug, Damelin, More, Hadebe, Vorster and Tsabedze.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author MS declared that they were an editorial board member of Frontiers at the time of submission. This had no impact on the peer review process or the final decision.

Auteurs

Dineo Mpanya (D)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Mike Sathekge (M)

Department of Nuclear Medicine, University of Pretoria, Pretoria, Gauteng, South Africa.
Nuclear Medicine Research Infrastructure, Steve Biko Academic Hospital, Pretoria, South Africa.

Eric Klug (E)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Netcare Sunninghill, Sunward Park Hospitals, Johannesburg, South Africa.

Jenna Damelin (J)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Stuart More (S)

Division of Nuclear Medicine, Department of Radiation Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Bawinile Hadebe (B)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
Department of Nuclear Medicine, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.

Mariza Vorster (M)

Department of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
Department of Nuclear Medicine, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.

Nqoba Tsabedze (N)

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Classifications MeSH